-- Apple, Corcept Therapeutics, Codexis: U.S. Equity Preview for Feb. 21
-- B y   K a t i a   P o r z e c a n s k i
-- 2012-02-17T22:52:49Z
-- http://www.bloomberg.com/news/2012-02-17/apple-corcept-therapeutics-codexis-u-s-equity-preview.html
Shares of the following companies
may have unusual moves in U.S. trading on Feb. 21. U.S. markets
will be closed on Feb. 20 for the Presidents’ Day holiday. Stock
symbols are in parentheses, and prices are as of 5:40 p.m. in
New York.  Standard & Poor’s 500 Index futures expiring in March rose
0.4 percent to 1,359.70.  Apple Inc. (AAPL)  : HTC Corp. lost a patent-infringement
claim against the world’s largest technology company at the U.S.
International Trade Commission, the first of the Taiwanese
handset maker’s cases targeting the iPhone.  Corcept Therapeutics Inc. (CORT)  : The specialty drug
company that hasn’t generated revenue since 2009 won approval
for its leading product candidate, a treatment that uses the
active ingredient of the abortion pill RU-486 to treat Cushing’s
Syndrome.  Codexis Inc. (CDXS)  : Alan Shaw resigned as president and
chief executive officer of the company, which makes enzymes used
in producing drugs. He will continue to serve as an adviser to
the board of directors. The board appointed Peter Strumph,
business head of pharmaceuticals, as interim CEO.  To contact the reporter on this story:
Katia Porzecanski in  New York  at 
 kporzecansk1@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  